The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Sep. 18, 2012
Filed:
Aug. 06, 2009
Karin Conde-knape, Englewood, NJ (US);
Waleed Danho, Wayne, NJ (US);
George Ehrlich, New York, NY (US);
Nader Fotouhi, Basking Ridge, NJ (US);
David Charles Fry, Langhorne, PA (US);
Wajiha Khan, East Hanover, NJ (US);
Anish Konkar, Guttenberg, NJ (US);
Cristina Martha Rondinone, West Milford, NJ (US);
Joseph Swistok, Nutley, NJ (US);
Rebecca Anne Taub, Villanova, PA (US);
Jefferson Wright Tilley, North Caldwell, NJ (US);
Karin Conde-Knape, Englewood, NJ (US);
Waleed Danho, Wayne, NJ (US);
George Ehrlich, New York, NY (US);
Nader Fotouhi, Basking Ridge, NJ (US);
David Charles Fry, Langhorne, PA (US);
Wajiha Khan, East Hanover, NJ (US);
Anish Konkar, Guttenberg, NJ (US);
Cristina Martha Rondinone, West Milford, NJ (US);
Joseph Swistok, Nutley, NJ (US);
Rebecca Anne Taub, Villanova, PA (US);
Jefferson Wright Tilley, North Caldwell, NJ (US);
Hoffmann-La Roche Inc., Nutley, NJ (US);
Abstract
Provided herein are neuropeptide-2 receptor agonists of the formula (I): as well as pharmaceutically acceptable salts, derivatives and fragments thereof, wherein the substituents are as those disclosed in the specification. X is 4-oxo-6-(1-piperazinyl)-3(4H)-quinazoline-acetic acid (Pqa). These compounds, and the pharmaceutical compositions containing them, are useful for the treatment of diseases such as, for example, obesity and diabetes.